Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
NHL9503
Study information
Scientific title
Non-Hodgkins lymphoma T-cell protocol
Acronym
Study hypothesis
Not provided at time of registration
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Hospitals
Trial type
Treatment
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Lymphoma (non-Hodgkin's)
Intervention
1. Group A: Chemotherapy including third intensification block at 35 weeks
2. Group B: Chemotherapy without third intensification block at 35 weeks
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measures
Not provided at time of registration
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/01/1997
Overall trial end date
28/02/2000
Reason abandoned
Eligibility
Participant inclusion criteria
1. T-cell non-Hodgkin's lymphoma
2. Stages I-IV
3. Confirmed remission achieved
4. Less than 25% blasts in bone marrow
5. No circulating blasts in blood
6. Aged <18 years
Participant type
Patient
Age group
Child
Gender
Both
Target number of participants
Not provided at time of registration
Participant exclusion criteria
Patients with T-cell anaplastic lymphoma or peripheral T-cell lymphoma are excluded.
Recruitment start date
01/01/1997
Recruitment end date
28/02/2000
Locations
Countries of recruitment
United Kingdom
Trial participating centre
MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom
Sponsor information
Organisation
Cancer Research UK (CRUK) (UK)
Sponsor details
PO Box 123
Lincoln's Inn Fields
London
WC2A 3PX
United Kingdom
+44 (0)207 317 5186
kate.law@cancer.org.uk
Sponsor type
Charity
Website
Funders
Funder type
Charity
Funder name
Cancer Research UK
Alternative name(s)
CRUK
Funding Body Type
private sector organisation
Funding Body Subtype
other non-profit
Location
United Kingdom
Funder name
United Kingdom Children's Cancer Study Group (UKCCSG)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary